|AHFS/Drugs.com||International Drug Names|
|Elimination half-life||10 hours|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||371.53 g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers. It also acts as a β3 receptor agonist. A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as "β-adrenergic blocking, antiarrhythmic compound S-596".
It is used in the treatment of high blood pressure and essential tremor. Recommended dosage is 10 to 30 mg per day.